Sherwin-Williams
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 13:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 8-K | 2026-11-02 | Read on SEC.gov |
| 10-Q | 2026-10-27 | Read on SEC.gov |
| 8-K | 2026-10-27 | Read on SEC.gov |
| 8-K | 2026-09-29 | Read on SEC.gov |
| 10-Q | 2026-07-28 | Read on SEC.gov |
| 8-K | 2026-07-28 | Read on SEC.gov |
| 8-K | 2026-06-09 | Read on SEC.gov |
| 10-Q | 2026-04-28 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 04:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $23.57B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Net income | $2.57B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Operating cash flow | $3.45B | Annual | 2025-12-31 | 2026-02-19 | 10-K |
| Total assets | $25.90B | As of | 2025-12-31 | 2026-02-19 | 10-K |
| Stockholders’ equity | $4.60B | As of | 2025-12-31 | 2026-02-19 | 10-K |
| Cash and cash equivalents | $207.20M | As of | 2025-12-31 | 2026-02-19 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 3.72, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Paint Stores Group is the largest reported line at 58.54% of revenue, across 4 reported segments.
- Consumer Brands Group follows at 36.28%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +2.06% YoY
Margins
- Gross margin
- 48.85%
- Operating margin
- 16.11%
- Net margin
- 10.90%
Key ratios & quality
- Enterprise valuei
- 93.22B
- PEG ratioi
- 3.75
- Altman Z-Scorei
- 3.72
PEG uses trailing P/E against the 3-year net income growth rate (8.33%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.53B | 17.90B | 18.36B | 19.94B | 22.15B | 23.05B | 23.10B | 23.57B |
| Gross profit | 7.42B | 8.04B | 8.68B | 8.54B | 9.33B | 10.76B | 11.20B | 11.52B |
| Selling & admin expenses | 5.03B | 5.27B | 5.48B | 5.88B | 6.33B | 7.07B | 7.43B | 7.70B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.89B | 2.43B | 2.85B | 2.66B | 3.00B | 3.61B | 3.76B | 3.80B |
| Pretax profit | 1.36B | 1.98B | 2.52B | 2.25B | 2.57B | 3.11B | 3.45B | 3.34B |
| Tax | 251.00M | 440.50M | 488.80M | 384.20M | 553.00M | 721.10M | 770.40M | 769.70M |
| Net profit | 1.11B | 1.54B | 2.03B | 1.86B | 2.02B | 2.39B | 2.68B | 2.57B |
| Basic EPS | 4 | 6 | 7 | 7 | 8 | 9 | 11 | 10 |
| Diluted EPS | 3.89 | 5.50 | 7.36 | 6.98 | 7.72 | 9.25 | 10.55 | 10.26 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 6.31B | 6.36B | 5.60B | 5.67B | 6.79B | 6.86B |
| Gross profit | 3.12B | 3.13B | 2.71B | 2.78B | 3.34B | 3.28B |
| Selling & admin expenses | 2.02B | 1.96B | 1.92B | 1.98B | 2.10B | 2.07B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.10B | 1.15B | 789.70M | 802.70M | 1.23B | 1.21B |
| Pretax profit | 985.70M | 1.06B | 639.00M | 679.80M | 1.11B | 1.06B |
| Tax | 231.00M | 227.40M | 162.20M | 145.10M | 268.90M | 242.50M |
| Net profit | 754.70M | 833.10M | 476.80M | 534.70M | 843.60M | 821.00M |
| Basic EPS | 3 | 3 | 2 | 2 | 3 | 3 |
| Diluted EPS | 3.00 | 3.35 | 1.92 | 2.15 | 3.43 | 3.38 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.34B | 4.63B | 4.59B | 5.05B | 5.91B | 5.51B | 5.40B | 6.01B |
| Cash & ST investments | 155.50M | 161.80M | 226.60M | 165.70M | 198.80M | 276.80M | 210.40M | 207.20M |
| Inventory | 1.82B | 1.89B | 1.80B | 1.93B | 2.63B | 2.33B | 2.29B | 2.32B |
| Total assets | 19.13B | 20.50B | 20.40B | 20.67B | 22.59B | 22.95B | 23.63B | 25.90B |
| Total current liabilities | 4.30B | 4.52B | 4.59B | 5.72B | 5.96B | 6.63B | 6.81B | 6.92B |
| Short-term debt | 635.60M | 1.01B | 412.50M | 1.43B | 1.40B | 1.92B | 2.18B | 2.03B |
| Long-term debt | 8.71B | 8.05B | 8.27B | 8.59B | 9.59B | 8.38B | 8.18B | 9.32B |
| Total liabilities | 15,403,600,000.00 | 16,372,900,000.00 | 16,790,800,000.00 | 18,229,500,000.00 | 19,491,900,000.00 | 19,238,600,000.00 | 19,581,400,000.00 | 21,303,400,000.00 |
| Total equity | 3.73B | 4.12B | 3.61B | 2.44B | 3.10B | 3.72B | 4.05B | 4.60B |
| Retained earnings | 6.25B | 7.37B | 844.30M | 2.12B | 3.52B | 5.29B | 7.25B | 1.03B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 6.43B | 6.15B | 6.01B | 6.50B | 7.00B | 7.03B |
| Cash & ST investments | 269.80M | 241.50M | 207.20M | 216.90M | 293.50M | 264.20M |
| Inventory | 2.48B | 2.28B | 2.32B | 2.47B | 2.53B | 2.55B |
| Total assets | 25.36B | 26.21B | 25.90B | 26.38B | 26.95B | 26.96B |
| Total current liabilities | 8.20B | 7.47B | 6.92B | 7.53B | 9.63B | 9.85B |
| Short-term debt | 3.34B | 2.68B | 2.03B | 2.86B | 4.23B | 4.34B |
| Long-term debt | 7.83B | 9.32B | 9.32B | 9.32B | 8.33B | 7.94B |
| Total liabilities | 20,962,700,000.00 | 21,781,100,000.00 | 21,303,400,000.00 | 21,947,600,000.00 | 23,096,700,000.00 | 22,984,700,000.00 |
| Total equity | 4.40B | 4.43B | 4.60B | 4.43B | 3.85B | 3.98B |
| Retained earnings | 8.11B | 8.74B | 1.03B | 1.37B | 2.01B | 2.64B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.94B | 2.32B | 3.41B | 2.24B | 1.92B | 3.52B | 3.15B | 3.45B |
| Depreciation & amortization | 596.30M | 574.90M | 581.40M | 572.60M | 581.10M | 622.50M | 624.00M | 676.90M |
| Free cash flow | 1.69B | 1.99B | 3.10B | 1.87B | 1.28B | 2.63B | 2.08B | 2.65B |
| Dividends paid | -322.90M | -420.80M | -488.00M | -587.10M | -618.50M | -623.70M | -723.40M | -789.80M |
| Stock buybacks / issuance | -613.30M | -778.80M | -2.26B | -2.74B | -861.20M | -1.43B | -1.74B | -1.66B |
| Ending cash balance | 155.50M | 161.80M | 226.60M | 165.70M | 198.80M | 276.80M | 210.40M | 207.20M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.11B | 1.31B | 1.09B | 139.10M | 1.35B | 1.10B |
| Depreciation & amortization | 162.70M | 166.90M | 186.40M | 186.80M | 186.40M | 187.50M |
| Free cash flow | 931.10M | 1.11B | 862.10M | 800.00K | 1.24B | 975.80M |
| Dividends paid | -197.90M | -195.70M | -195.80M | -197.10M | -197.50M | -194.30M |
| Stock buybacks / issuance | -518.50M | -668.20M | -118.00M | -575.60M | -1.26B | -520.10M |
| Ending cash balance | 269.80M | 241.50M | 207.20M | 216.90M | 293.50M | 264.20M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 29.87 | 39.25 | 52.51 | 61.65 | 72.94 | 70.07 | 69.05 | 59.39 |
| ROA %i | 5.67 | 7.78 | 9.93 | 9.08 | 9.34 | 10.49 | 11.51 | 10.37 |
| ROIC %i | 10.29 | 12.98 | 16.28 | 15.46 | 15.71 | 17.28 | 19.03 | 17.41 |
| 5-year avg ROE %i | 70.31 | 65.47 | 53.37 | 49.20 | 51.28 | 59.28 | 65.24 | 66.62 |
| EBIT margin %i | 9.85 | 13.02 | 15.57 | 12.95 | 13.38 | 15.30 | 16.74 | 16.13 |
| FCF / sales %i | 9.65 | 11.13 | 16.91 | 9.39 | 5.76 | 11.42 | 9.02 | 11.26 |
| Current ratioi | 1.01 | 1.02 | 1.00 | 0.88 | 0.99 | 0.83 | 0.79 | 0.87 |
| Quick ratioi | 0.51 | 0.50 | 0.50 | 0.44 | 0.46 | 0.41 | 0.38 | 0.43 |
| Debt / assetsi | 48.83 | 50.88 | 49.57 | 55.62 | 55.36 | 51.45 | 50.41 | 49.97 |
| LT debt / equityi | 233.42 | 228.49 | 268.67 | 412.83 | 357.95 | 266.09 | 240.30 | 237.31 |
| Interest coveragei | 4.71 | 6.67 | 8.40 | 7.72 | 7.58 | 8.45 | 9.30 | 8.18 |
| Revenue CAGR (3Y) %i | 15.64 | 14.72 | 7.01 | 4.39 | 7.36 | 7.88 | 5.02 | 2.10 |
| Net income CAGR (3Y) %i | 1.71 | 10.81 | 5.52 | 18.92 | 9.44 | 5.57 | 12.88 | 8.33 |
| FCF CAGR (3Y) %i | 11.74 | 23.04 | 23.18 | 3.42 | -13.82 | -5.34 | 3.62 | 27.67 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 62.43 | 59.94 | 59.39 | 60.72 | 65.12 | 63.70 |
| ROA %i | 10.37 | 10.25 | 10.37 | 10.19 | 10.28 | 10.07 |
| ROIC %i | 17.23 | 16.93 | 17.41 | 16.90 | 17.45 | 17.10 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.01 | 16.10 | 16.13 | 16.12 | 16.42 | 16.19 |
| FCF / sales %i | 9.34 | 10.42 | 11.26 | 12.14 | 13.16 | 12.35 |
| Current ratioi | 0.78 | 0.82 | 0.87 | 0.86 | 0.73 | 0.71 |
| Quick ratioi | 0.41 | 0.45 | 0.43 | 0.45 | 0.40 | 0.39 |
| Debt / assetsi | 50.35 | 51.81 | 49.97 | 52.26 | 52.74 | 51.86 |
| LT debt / equityi | 214.32 | 246.32 | 237.31 | 246.56 | 259.01 | 242.46 |
| Interest coveragei | 8.84 | 8.67 | 8.18 | 7.83 | 7.76 | 7.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.
Sherwin-Williams discussion 0 comments